Endologix LLC Completes Patient Enrollment in the ELEVATE IDE Clinical Study - Endologix

Skip to content

PAD
AAA
IFU’s
About Us

PAD
AAA
IFU’s
About Us

Search

February 5, 2018

Endologix LLC Completes Patient Enrollment in the ELEVATE IDE Clinical Study

PrevPreviousEndologix Appoints Greg Morrow as Chief Marketing Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NextJohn McDermott Steps Down as Chief Executive Officer of Endologix LLCNext

Youtube Linkedin Twitter

Safety Information

Anti-Trafficking/Modern Slavery

Carbon Reduction Plan UK

Terms & Conditions

© 2026 Endologix LLC. All rights reserved.

Endologix^® products and associated components are not available in all countries or regions. Please contact your Endologix representative for details regarding product availability. Prior to use, refer to the “Instructions for Use” for complete and specificindications, contraindications, all warnings and precautions. Rx only.